Xenon Pharmaceuticals Statistics

Total Valuation

XENE has a market cap or net worth of $3.01 billion. The enterprise value is $2.38 billion.

Market Cap	3.01B
Enterprise Value	2.38B

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

XENE has 75.43 million shares outstanding. The number of shares has increased by 10.48% in one year.

Shares Outstanding	75.43M
Shares Change (YoY)	+10.48%
Shares Change (QoQ)	+6.01%
Owned by Insiders (%)	0.38%
Owned by Institutions (%)	99.99%
Float	69.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.24
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.65, with a Debt / Equity ratio of 0.01.

Current Ratio	23.65
Quick Ratio	23.43
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.20% and return on invested capital (ROIC) is -22.80%.

Return on Equity (ROE)	-25.20%
Return on Assets (ROA)	-24.00%
Return on Capital (ROIC)	-22.80%
Revenue Per Employee	n/a
Profits Per Employee	-$704,220
Employee Count	259
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-292,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.95% in the last 52 weeks. The beta is 1.18, so XENE's price volatility has been higher than the market average.

Beta (1Y)	1.18
52-Week Price Change	+4.95%
50-Day Moving Average	44.92
200-Day Moving Average	39.69
Relative Strength Index (RSI)	31.73
Average Volume (30 Days)	364,311

Short Selling Information

The latest short interest is 2.76 million, so 3.65% of the outstanding shares have been sold short.

Short Interest	2.76M
Short Previous Month	2.62M
Short % of Shares Out	3.65%
Short % of Float	3.96%
Short Ratio (days to cover)	7.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-214.05M
Pretax Income	-182.69M
Net Income	-182.39M
EBITDA	-179.14M
EBIT	-182.69M
Earnings Per Share (EPS)	-$2.73

Full Income Statement

Balance Sheet

The company has $638.08 million in cash and $10.90 million in debt, giving a net cash position of $627.18 million or $8.31 per share.

Cash & Cash Equivalents	638.08M
Total Debt	10.90M
Net Cash	627.18M
Net Cash Per Share	$8.31
Equity / Book Value	927.92M
Book Value Per Share	12.30
Working Capital	617.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$145.33 million and capital expenditures -$5.62 million, giving a free cash flow of -$150.94 million.

Operating Cash Flow	-145.33M
Capital Expenditures	-5.62M
Free Cash Flow	-150.94M
FCF Per Share	-$2.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XENE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.48%
Shareholder Yield	-10.48%
Earnings Yield	-6.06%
FCF Yield	-5.02%

Dividend Details

Analyst Forecast

The average price target for XENE is $58.00, which is 45.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$58.00
Price Target Difference	45.44%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2